Tag: Acquisition
Infinity BiologiX Acquires UK Based Roylance Pharma to Expand into Europe
IBX, a global leader in biobanking, bioprocessing and analytics, has acquired UK based biospecimen storage specialists Roylance Pharma.
“We are excited to welcome the Roylance Pharma team into the IBX family. Combining our two great organisations serves to strengthen the...
BioIVT Acquires Tissue Solutions, a UK-based Virtual Biobank
BioIVT, a leading provider of research models and services for drug and diagnostic development, just announced the acquisition of Tissue Solutions Ltd., a virtual biobank based in Glasgow, UK. Tissue Solutions provides medical researchers with high quality human tissue and...
Quest Diagnostics Sells Remaining Stake in Q² Solutions to IQVIA for $760 million
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, just announced the sale of its minority share in Q2 Solutions to IQVIA (NYSE: IQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the...
Cryoport Acquires MVE Biological Solutions from Chart Industries for $320 million
Cryoport will become a leading global provider of cryogenic life sciences solutions
Acquisitions of MVE, along with CRYOPDP is expected to increase Cryoport's revenue run rate to over $160 million and to be immediately accretive
Blackstone to invest...
BioLife Solutions Expands The Product Line By Acquiring Custom Biogenic Systems
BioLife Solutions, Inc., a leading developer and supplier of
a portfolio of best-in-class bioproduction tools for cell and gene therapies,
today announced the acquisition of substantially all of the assets of Custom
Biogenic Systems, Inc. ("CBS"), a privately held company. BioLife Solutions, founded...
Discovery Life Sciences™ Acquires QualTek Molecular Laboratories
Discovery Life Sciences™ (Discovery) has acquired QualTek
Molecular Laboratories (QualTek), a renowned provider of immunohistochemistry
(IHC) services with CAP/CLIA-accredited and Good Laboratory Practice-(GLP)
capable laboratories in California and Pennsylvania, respectively. QualTek's
acquisition significantly augments Discovery's existing histopathology services
and creates a uniquely powerful suite...
Biodesix Acquires Oncimmune’s US Based Laboratory Assets And IPN Malignancy Test
Biodesix, Inc., has completed acquisition of Oncimmune’s
laboratory and incidental pulmonary nodule (IPN) malignancy test in the United
States, further extending the company’s blood-based lung cancer diagnostic
portfolio. Oncimmune’s U.S. commercial and lab operations, including a Clinical
Laboratory Improvement Amendments (CLIA) lab in...
OpGen Acquires Curetis To Advance Data-Driven Diagnostics For Infectious Disease
OpGen, Inc., and Curetis N.V., a developer of next-level
molecular diagnostic solutions, have entered into a definitive agreement to
combine the two companies’ businesses, subject to approval by both companies’
respective shareholders and Curetis’ debt financing providers. The transaction
is structured as an...